Oligosaccharide Mixture for Infant Formula Allergy Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current infant formulas lack an oligosaccharide mixture that effectively mimics the composition of human milk to promote beneficial gut bacteria and reduce the risk of food allergies, while maintaining a balanced metabolism and immune status.
Innovation Solution
An oligosaccharide mixture comprising N-acetylated, galacto-, sialylated, and fucosylated oligosaccharides, structurally closer to human breast milk oligosaccharides, which is incorporated into a food product to selectively promote beneficial bacteria in the colon, reducing food allergy risks and improving immune and metabolic balance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional prebiotic mixtures (FOS and GOS) are added to infant formula, then beneficial bacteria growth is stimulated, but the composition only provides an approximation to human milk oligosaccharides and does not fully promote beneficial gut bacteria
Solution Approach 1:
The patent changes the compositional parameters of the prebiotic mixture by incorporating specific human milk oligosaccharides (HMOs) such as 2'-fucosyllactose, lacto-N-fucopentaose I, III, and V, and sialylated oligosaccharides in defined proportions that match human milk composition, thereby achieving both effectiveness and compositional accuracy
Solution Approach 2:
The patent creates a composite oligosaccharide mixture combining multiple types of HMOs including fucosylated, sialylated, and neutral oligosaccharides in specific ratios, which together provide synergistic effects in promoting beneficial bacteria while accurately replicating human milk composition
2Object-affected harmful factors
If infant formula is supplemented with prebiotics to promote beneficial bacteria, then gut health is improved, but the formula does not fully replicate the complex microbiota-promoting effects of human milk
Solution Approach 1:
The patent optimizes the concentration and composition parameters of HMOs in the formula to match human milk levels, creating an environment that selectively promotes bifidobacteria and other beneficial bacteria while reducing food allergy risk through the specific immunomodulatory properties of HMOs
3Ease of manufacture
If a simplified prebiotic mixture is used in infant formula, then manufacturing is easier, but the mixture does not accurately replicate human milk oligosaccharide composition
Solution Approach 1:
The patent defines specific concentration ranges for each HMO component (e.g., 2'-fucosyllactose at 0.2-2.0 g/L, lacto-N-fucopentaose I at 0.1-1.0 g/L) that balance manufacturing feasibility with compositional accuracy, allowing standardized production while maintaining human milk-like properties
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The oligosaccharide mixture effectively reduces the risk and severity of food allergies, enhances oral tolerance to allergens, and improves gut health by promoting beneficial bacteria, making it suitable for infants and adults alike.
Implementation Method 1
They are non-digestible in the sense that they are not broken down and absorbed in the stomach or small intestine and thus pass intact to the colon where they are selectively fermented by the beneficial bacteria
Data Source
AI summary
The invention discloses an oligosaccharide mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide, 5-90 wt % of at least one neutral oligosaccharide, 2-50 wt % of at least one sialylated oligosaccharide, and/or 5-70 wt % of at least one fucosylated oligosaccharide. The invention also discloses a food product, especially an infant formula, comprising said oligosaccharide mixture.